Detailed information |
---|
CancerLivER ID | 2356 |
Biomarker | PTPRD |
Biomarker Name/Symbol (given in Publication) | PTPRD |
Biomolecule | RNAs |
Subject | Human |
Degree of Validity | Differentially expressed in HCCs with PVI in comparison with HCCs without PVI; but not validated on independent dataset |
Experimental Condition | HCC with PVI v/s HCC without PVI |
Cancer type | Hepatocellular carcinoma |
Regulation | Downregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.15) |
Level of significance | p < 0.05 |
Source | Tissue |
PMID | 17088983 |
Type of Biomarker | Prognostic |
Pathway | Signal transduction |
Cohort | 14 HCCs with PVI and 21 HCCs without PVI. |
Sensitivity | NA |
Specificity | NA |
Accuracy | NA |
AUC | NA |
Disease | HCV associated HCC |
Year of Publication | 2006 |
Clinical trial | NO |
Clinical trial (NCT Number) | NA |